Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
21,509 Breast Cancer
clinical trials

Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Stockton, CA
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Summit, WI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Sunset Hills, MO
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Syracuse, NY
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Tacoma, WA
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Thomasville, GA
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Topeka, KS
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Tucson, AZ
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Twin Falls, ID
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Uniontown, PA
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Vacaville, CA
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Valdosta, GA
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wadsworth, OH
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Walla Walla, WA
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Washington, MO
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Waterford, CT
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Waukesha, WI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wausau, WI
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
West Chester, PA
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
West Columbia, SC
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Willmar, MN
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wyoming, MI
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Portland, OR
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Durham, NC
Click here to add this to my saved trials
Oncology Clinical Trial
A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older
Status: Enrolling
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Durham, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
TR(ACE) Assay Clinical Specimen Study
Status: Enrolling
Updated: 1/16/2018
mi
from
Bloomington, IN
Click here to add this to my saved trials
Oncology Clinical Trial
A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Aurora, CO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Neoplasms Clinical Trial
Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Augusta, GA
Click here to add this to my saved trials
Neoplasms Clinical Trial
Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Neoplasms Clinical Trial
Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fairfax, VA
Click here to add this to my saved trials
Neoplasms Clinical Trial
Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Kansas City, MO
Click here to add this to my saved trials
Neoplasms Clinical Trial
Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Rochester, MN
Click here to add this to my saved trials
Neoplasms Clinical Trial
Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
San Antonio, TX
Click here to add this to my saved trials
Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma Clinical Trial
A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma Clinical Trial
A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Nashville, TN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Dallas, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery
Status: Enrolling
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Study Evaluating MM-310 in Patients With Solid Tumors
Status: Enrolling, Phase I
Updated: 11/29/2017
mi
from
Buffalo, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Study Evaluating MM-310 in Patients With Solid Tumors
Status: Enrolling, Phase I
Updated: 11/29/2017
mi
from
Durham, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Study the Use of Magseed and Sentimag to Localize Axillary Lymph Nodes
Status: Enrolling, Phase IV
Updated: 3/21/2018
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer.
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Multi-epitope Folate Receptor Alpha Peptide Vaccine, Sargramostim, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Falls Church, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Multi-epitope Folate Receptor Alpha Peptide Vaccine, Sargramostim, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Marshfield, WI
Click here to add this to my saved trials
Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Clinical Trial
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Baltimore, MD
Click here to add this to my saved trials
Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Clinical Trial
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Seattle, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Bremerton, WA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Falls Church, VA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Portland, OR
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
San Diego, CA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Seattle, WA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Aberdeen, SD
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Albany, GA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Allentown, PA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Annapolis, MD
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Aurora, CO
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Baltimore, MD
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Baltimore, MD
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Barberton, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Bardstown, KY
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Bellingham, WA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Belpre, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Berkeley, CA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Billings, MT
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Bismarck, ND
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Boulder, CO
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Bremerton, WA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Bristol, TN
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Brookfield, WI
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Centerville, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Charleston, SC
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Charlotte, NC
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Clackamas, OR
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Clive, IA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials